Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
Post induction inotuzumab
Post induction inotuzumab for newly diagnosed ALL
Status:
Open
Trial Type:
Acute Lymphoblastic Leukemia (Pediatric)
Contact:
Jennifer Welch, MD
jwelch@brownhealth.org
